Sandia Holdings’s Kura Oncology KURA Stock Holding History

Sandia Holdings’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-60,240	Closed	-$922K	–	25
2017 Q4	$922K	Buy	+60,240	New	+$888K	0.42%	25

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Sandia Holdings's KURA Position: Q1 2018 in Review

Sandia Holdings sold out of Kura Oncology (KURA) in Q1 2018, closing a stake of 60,240 shares — an estimated $922K sold.

Sandia Holdings first reported a position in KURA in Q4 2017 and held it in 1 quarter. The position peaked at $922K in Q4 2017. 98 funds tracked by Wall St. Rank hold KURA as of Q1 2018.

Sandia Holdings reported no remaining Kura Oncology position as of Q1 2018 after selling out during the quarter.
Sandia Holdings sold 60,240 Kura Oncology shares in Q1 2018, an estimated $922K.
Sandia Holdings first reported a position in Kura Oncology in Q4 2017 and held it in 1 quarter.
Sandia Holdings's Kura Oncology position peaked at $922K in Q4 2017.
98 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2018.

Based on Sandia Holdings's 13F filing for Q1 2018, filed 11 May 2018.